| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 140.975 | 144.754 | 134.944 | 129.455 | 112.937 | 81.339 | 120.229 | 151.458 | 76.833 | 724 |
| Total Income - EUR | 140.970 | 144.754 | 134.945 | 129.455 | 113.142 | 81.339 | 120.229 | 151.458 | 76.833 | 850 |
| Total Expenses - EUR | 136.767 | 139.446 | 129.481 | 127.920 | 122.247 | 81.940 | 106.570 | 120.708 | 81.042 | 10.830 |
| Gross Profit/Loss - EUR | 4.203 | 5.307 | 5.464 | 1.535 | -9.105 | -600 | 13.659 | 30.750 | -4.210 | -9.980 |
| Net Profit/Loss - EUR | 3.528 | 4.458 | 3.004 | 240 | -10.237 | -1.388 | 12.481 | 29.462 | -4.978 | -9.988 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bioparapharm Life Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 378 | 19.568 | 19.018 | 646 | 634 | 0 | 0 | 0 | 0 |
| Current Assets | 21.277 | 27.904 | 29.891 | 27.033 | 20.660 | 19.986 | 22.860 | 65.362 | 26.849 | 419 |
| Inventories | 45 | 7.978 | 10.298 | 14.441 | 11.202 | 7.744 | 8.306 | 20.268 | 2.519 | 0 |
| Receivables | 8.526 | 8.314 | 10.514 | 8.629 | 7.782 | 9.984 | 5.965 | 2.239 | 17.529 | 0 |
| Cash | 12.706 | 11.612 | 9.079 | 3.962 | 1.676 | 2.258 | 8.589 | 42.855 | 6.801 | 419 |
| Shareholders Funds | 3.016 | 7.444 | 10.322 | 10.372 | -66 | -1.453 | 11.060 | 40.557 | -9.210 | -19.146 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 18.261 | 20.838 | 39.137 | 35.679 | 21.372 | 22.073 | 11.800 | 24.805 | 36.058 | 19.565 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Bioparapharm Life Srl